(CIDRAP News) – Opening the 65th annual World Health Assembly (WHA) today, World Health Organization (WHO) Director-General Margaret Chan, MD, said she sees a bright future for health development, despite financial crises that many countries are facing, which has shrunk support for many initiatives.
(CIDRAP News) A World Health Assembly (WHA)committee that took up a resolution to destroy the remaining stocks of smallpox virus failed to reach an agreement today, despite a working group's attempts to find an acceptable solution.
(CIDRAP News) An article published by the British Medical Journal says three scientists who helped frame World Health Organization (WHO) guidance on pandemic influenza preparedness had consulted for pharmaceutical companies that stood to profit from the WHO guidance and that the WHO did not disclose the scientists' industry ties.
(CIDRAP News) The World Health Organization (WHO) today said it is in the final stages of putting together an independent committee to review its preparation for and response to the H1N1 pandemic, a group of about 29 experts that will meet for the first time in the middle of April.
(CIDRAP News) Sanofi Pasteur pledged today to give 60 million doses of H5N1 influenza vaccine over 3 years to the World Health Organization (WHO) for a planned stockpile to help poor countries in the event of an influenza pandemic.
(CIDRAP News) A World Health Organization (WHO) group that recently met to work out an agreement to ease the global sharing of H5N1 avian influenza viruses failed to resolve the issue, but signaled that work on the issues would continue.
(CIDRAP News) This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.
TORONTO (CIDRAP News) The continuing debate over developing countries' ability to afford pandemic-influenza vaccines has produced a disturbing complication: the possibility that Indonesia and other countries affected by H5N1 avian flu will assert legal ownership of the viral isolates on which the vaccines would be based.